| Intrahepatic Cholangiocarcinoma studied in …STUDIED_INderived200 of 227show all (up to 200) |
|---|
| → studied in | NCT07715903Phase 1 · not yet recruiting Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04175912Phase 2 · active not recruiting Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07766187Phase 2 · not yet recruiting Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07846267Phase 2 · not yet recruiting Cryoablation Combined With Anlotinib Plus TQB2868 in Patients With Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07847710Phase 2 · recruiting Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II Trial · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05712356Phase 2 · completed A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07841574Phase 2 · recruiting HAIC Plus QL1706 & Bevacizumab in Unresectable HER2-Negative ICC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06888063Phase 2 · recruiting Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07522476Phase 2 · recruiting A Clinical Study to Evaluate the Efficacy and Safety of VG2025 in Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06375915Phase 2 · recruiting Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04708067Phase 1 · active not recruiting Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07814586not yet recruiting Prognostic Evaluation and Systematic Re-Assessment of Cholangiocarcinoma Therapy · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07161869recruiting Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07780838Phase 2 · recruiting Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06050252Phase 2 · suspended Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05286814Phase 2 · recruiting PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06728410Phase 2 · recruiting A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07632235Phase 1/Phase 2 · not yet recruiting A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07793253Phase 2 · not yet recruiting Phase 2 Study of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04891289Phase 2 · recruiting Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07768085NA · not yet recruiting Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07765433Phase 2/Phase 3 · not yet recruiting Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07760038NA · recruiting Protective Mechanisms of Phycocyanin in Partial Hepatectomy-Associated Liver Injury · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06160752Phase 1 · active not recruiting Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564403Phase 2 · active not recruiting Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05285358Phase 1 · recruiting Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07716345not yet recruiting Inter-Individual Tumor Heterogeneity on 3D-MRE for Predicting Response to Conversion Therapy in Liver Cancer · condition mapped ALIAS · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06990659NA · recruiting Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07707661not yet recruiting Application of Super-Resolution Ultrasound (SRUS) in Liver Tumor · condition mapped ALIAS · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05422690Phase 2 · recruiting The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07704203not yet recruiting Preoperative 3D Magnetic Resonance Elastography for Predicting Surgical Risk in Patients Undergoing Hepatectomy · condition mapped ALIAS · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07704216not yet recruiting Peritumoral MRE Stiffness for Predicting Resection Margin Status and Recurrence in Liver Cancer · condition mapped ALIAS · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07691515Phase 3 · not yet recruiting Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02200042Phase 3 · terminated Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03942328Phase 1/Phase 2 · recruiting Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06342414recruiting An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06101277NA · recruiting Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07169734Phase 1/Phase 2 · recruiting A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01862315Phase 2 · completed Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07658586active not recruiting AI Multimodal Model for Liver Cancer Diagnosis and Prognosis · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04251715Phase 2 · terminated mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06925516Phase 2 · recruiting A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07646717Phase 2 · active not recruiting Efficacy and Safety of HAIC Combined With Lenvatinib and PD-1 Inhibitors for Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07641036Phase 1/Phase 2 · recruiting Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07640048recruiting Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03257761Phase 1 · active not recruiting Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07614061Phase 1 · recruiting Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06058663Phase 1 · recruiting Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06735560NA · recruiting Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570849Phase 2 · recruiting Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05655949Phase 2 · recruiting Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06777316Phase 1/Phase 2 · active not recruiting A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07476651NA · recruiting Scout Dose of Resin Microspheres · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04834674Phase 2 · completed DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06910722NA · recruiting Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma After SIRT and Chemotherapy · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05240040withdrawn Treat Primary and Metastatic Liver Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06140134recruiting Liver Transplantation in Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07479264completed A Study on Intratumoral Fibrosis and α-SMA Expression in Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04301778Phase 2 · completed Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06381648completed Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07224737completed Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma. · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07225452completed An Exosomal miRNA-based Liquid Biopsy for ICC Detection · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06859684Phase 2 · recruiting Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07454486not yet recruiting TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04526106Phase 1/Phase 2 · completed REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07432568Phase 2 · not yet recruiting A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06178588Phase 2 · active not recruiting Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07223307Phase 2 · recruiting REGULUS: MRI-guided Adaptive SABR for Liver Cancers · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07201519Phase 2 · recruiting Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06313203Phase 2 · recruiting HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06739252Phase 2 · terminated Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05210322active not recruiting Percutaneous Cholangiopancreatoscopy Registry · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07364305Phase 2 · recruiting HAIC Combined With Immune Therapy for Advanced, Non-Resectable ICC · condition mapped ALIAS · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07353827Phase 2 · not yet recruiting FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07337850recruiting Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03768414Phase 3 · completed Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328919Phase 3 · not yet recruiting Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04353375Phase 2/Phase 3 · recruiting HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07304388Phase 2 · completed HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06420349Phase 1 · terminated NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04684862NA · active not recruiting Infusion System for Hepatic Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04238637Phase 2 · active not recruiting Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05174650Phase 2 · active not recruiting Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/Rearrangements · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07153783NA · completed Interventional AI-Human Collaboration for Liver Tumor Diagnosis · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02881554NA · terminated Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05328167Phase 2 · completed Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05220722Phase 1/Phase 2 · terminated Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07208526NA · not yet recruiting A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03044587Phase 2 · completed Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer · condition mapped ALIAS · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07176962recruiting A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04264260Phase 2 · completed Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04669496Phase 2/Phase 3 · active not recruiting Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07128290Phase 2 · not yet recruiting PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03579771Phase 2 · completed Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07070700Phase 2 · recruiting Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05678218completed Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05265208Phase 2 · recruiting Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07101237recruiting An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer. · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03377179Phase 2 · completed A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07043348terminated Streamlining Radioembolization for Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07063888Phase 2 · recruiting A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04561453terminated Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03781934Phase 1/Phase 2 · completed A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06572189early Phase 1 · withdrawn The Safety and Efficacy of CD-801 in Patients With Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06643208recruiting D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06370663Phase 2 · terminated First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04941287Phase 2 · active not recruiting Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06406816early Phase 1 · recruiting Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical Resection · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02807181Phase 2/Phase 3 · terminated SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05242822Phase 1 · terminated A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06956716Phase 1/Phase 2 · recruiting Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05239169Phase 2 · completed Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06946849Phase 2 · not yet recruiting Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06583993early Phase 1 · recruiting A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05342194Phase 3 · recruiting Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04634058Phase 2 · active not recruiting PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05565794Phase 2 · terminated Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04087876no longer available Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860477Phase 2 · recruiting Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01) · condition mapped ALIAS · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03414489no longer available Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06862934recruiting Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06208462Phase 2 · recruiting Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06852287Phase 2 · recruiting Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04299581Phase 2 · recruiting Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04954781Phase 2 · recruiting TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05010681Phase 2 · recruiting Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05010668Phase 2 · completed Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05236699Phase 2 · completed A Clinical Study of DEB-TACE Combined With Surufatinib and Camrelizumab in the Treatment of Inoperable or Metastatic ICC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05557578Phase 2 · recruiting GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04361331Phase 2 · completed Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06664021Phase 2 · recruiting Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04295317Phase 2 · active not recruiting PD-1 Antibody (SHR-1210) Plus Capecitabine in Patients with Intrahepatic Cholangiocarcinoma After Surgery · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02878473Phase 2 · terminated Liver Transplantation for Early Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06721286Phase 2 · recruiting Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06290739completed A Machine-learning Model to Predict Lymph Node Metastasis of Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239532Phase 2 · active not recruiting HAIC Sequential TAE Combined With Tislelizumab and Surufatinib in Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02512692NA · terminated Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06648525Phase 2 · not yet recruiting Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195503NA · enrolling by invitation Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06567600Phase 2 · not yet recruiting Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05223816Phase 2 · unknown An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06505486unknown GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05009953Phase 2 · terminated Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06298968Phase 2 · recruiting Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06417606Phase 4 · unknown Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06375642Phase 2 · unknown A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06296563Phase 2 · recruiting Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03201458Phase 2 · completed Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06335927Phase 2 · unknown HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06313554NA · not yet recruiting Surufatinib Combined With Toripalimab and HAIC in the Treatment of Inoperable or Metastatic Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05124002Phase 4 · unknown Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05292443withdrawn Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05678270Phase 2 · recruiting A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06098547NA · recruiting LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma (LIRICA) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01825603Phase 1 · completed ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05514912Phase 2 · withdrawn Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03230318Phase 2 · completed Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06134193Phase 2 · unknown Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05781958Phase 2 · unknown Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05930119Phase 1 · completed HMPL-453 Food Effect and PPI Study in Healthy Volunteer Study · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05681949NA · unknown Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05913661Phase 2 · unknown Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02520141Phase 2 · completed Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05896956not yet recruiting The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04454905Phase 2 · unknown Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05400902Phase 2 · unknown HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04556214NA · recruiting Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial) · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03849469Phase 1 · completed A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05672537Phase 2 · unknown Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05644743not yet recruiting Clinical Transformation of Organoid Model to Predict the Efficacy of GC in the Treatment of Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04078230NA · recruiting Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02415036Phase 2 · terminated Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05535647Phase 2 · unknown Second Line Therapy for Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04782804Phase 1/Phase 2 · unknown Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05489692completed HAIC Plus Targeted Therapy and/or PD-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05290116Phase 2 · unknown HAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04546828Phase 2 · withdrawn A Single-arm Study of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Resectable Oncologically High-Risk IHCC in Korea · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03316222Phase 1/Phase 2 · terminated Study of GNS561 in Patients With Liver Cancer · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327907unknown Establishment of Scoring Model for Early and Differential Diagnosis of Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05019677Phase 2 · withdrawn GP Chemotherapy in Combination With Tislelizumab and Ociperlimab as First-line Treatment in Advanced BTC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03086993Phase 2/Phase 3 · unknown Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05251662Phase 2 · unknown Sintilimab Combined With GEMOX ± IBI305 (Bevacizumab Biosimilar) Versus GEMOX in Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05247996NA · unknown TACE Combined With "Target Immune" Therapy for First-line Treatment in the Treatment of Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02392637Phase 2 · completed Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers · condition mapped CURATED_BROADER · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03796819NA · completed Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04511793NA · withdrawn Hepatic Artery Infusion (HAI) Program at Duke University · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04961788Phase 2 · unknown Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04961970Phase 3 · unknown HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03951597Phase 2 · unknown Combined Therapy Using Oxaliplatin and Gemcitabine Chemotherapy, Lenvatinib and PD1 Antibody (JS001) for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04479904Phase 2 · withdrawn A Trial of Famitinib in Patients With Failure of First-Line Treatment For Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03405909completed Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02273739Phase 1/Phase 2 · completed Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04398927Phase 2 · withdrawn Systemic Chemotherapy Plus PD-1 for Metastasis ICC · condition mapped ALIAS · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03251443Phase 2 · completed A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01938729Phase 1 · completed Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04527679Phase 2 · unknown Cisplatin and Gemcitabine Chemotherapy and Lenvatinib for Patients With Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04506281Phase 2 · unknown PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04413734Phase 2 · unknown Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma by AJCC v8 Stage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03801499Phase 2 · withdrawn Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma · condition mapped ONTOLOGY_EXACT · 227 trials mapped (107 active) | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |